Vastra Gotaland Region: Diabetes Mellitus trials
The registry lists 16 Diabetes Mellitus studies with Vastra Gotaland Region as lead sponsor. 3 are open to participants now and 0 have results posted.
Early Phase 1 1Phase 1 1Phase 2 1No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone ImplantRecruitingNCT06984822Not applicable
- The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 DiabetesNot yet recruitingNCT06471699Not applicable
- Gestational Diabetes - PrEvention of PostPartum Diabetes StudyRecruitingNCT05112588Not applicable
- Treatment Study in Patients Treated With Both Insulin & HydrocortisoneWithdrawnNCT05716607Not applicable
- A Trial of Diabetes-educated Psychologist to Improve HbA1c and Reduce Diabetes-related DistressActive, not recruitingNCT03753997Not applicable
- A Evaluation of Systematic Intensive Therapy Using CGM/FGM in Clinical Diabetes CareCompletedNCT03474393Not applicable
- Carbohydrate Content in the Diet in Type 1 DiabetesCompletedNCT03400618Not applicable
- Accuracy and Treatment Experience of Two Glucose Monitoring Systems Tested in Patients With Type 1 Diabetes and Renal ImpairmentCompletedNCT03378271Not applicable
- Evaluation of a Flash Glucose Monitoring System in Ambulatory Patients With Type 1 DiabetesCompletedNCT02677454Not applicable
- Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin InjectionsCompletedNCT02465411Not applicable
- Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 DiabetesCompletedNCT02159638Not applicable
- Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin InjectionsCompletedNCT02113332Phase 2
- CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin InjectionsCompletedNCT02092051Not applicable
- Metabolic Effects of Lactobacillus Reuteri DSM 17938 in Type 2 DiabetesCompletedNCT01836796Not applicable
- Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes PatientsCompletedNCT01620125Early Phase 1
- Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 DiabetesTerminatedNCT01238224Phase 1